For some time now, there has been evidence from randomized trials that the niacinamide (nicotinamide) form of vitamin B3 can prevent and treat certain forms of skin cancer. This includes a well-done phase 3 trial: ↪ Nicotinamide (vitamin B3) prevented skin cancer in high-risk patients in phase 3 trials. Many dermatologists now recommend it to patients at higher risk.
Now we have trials testing the niacin (nicotinic acid) form as a treatment for brain cancer: ↪ Niacin in a small glioblastoma pilot study: long survival, but historical controls. This is the same form that has been used in the past to lower cholesterol.
In both cases, the mechanism likely involves increasing NAD. In the case of skin cancer, niacinamide/NAD increases the effectiveness of DNA repair enzymes (PARPs) used to repair DNA damaged from UV. In the case of brain cancer, niacin/NAD appears to have a rejuvenative effect on the cancer-suppressed immune system, which in turn makes it more efficient at fighting the cancer.
It’s also worth noting that niacin (nicotinic acid) has shown some potential to treat glaucoma in a small human trial: ↪ Nicotinic acid (vitamin B3) may prevent or treat glaucoma, possibly via NAD.
Both the niacin (nicotinic acid) and nicotinamide riboside (NR) forms of vitamin B3 have also shown promise in treating Parkinson’s disease in small human trials: ↪ Niacin (nicotinic acid) showed promise in a small Parkinson's trial, likely via brain NAD.
In both glaucoma and Parkinson’s, the mechanism again appears to involve NAD.
#nadHD #nicotinamideHD #vitaminb3HD
#skincancerHD #cancerHD #niacinHD #glioblastomaHD #parpsHD #immunesystemHD #glaucomaHD #parkinsonsHD #nrHD





